Al Moustafa Ala-Eddin, Foulkes William D, Benlimame Naciba, Wong Annick, Yen Lily, Bergeron Josée, Batist Gerald, Alpert Lesley, Alaoui-Jamali Moulay A
Lady Davis Institute for Medical Research of the Sir Mortimer B. Davis-Jewish General Hospital, Department of Medicine, and Center for Translational Research in Cancer, Quebec, Canada.
Oncogene. 2004 Jan 15;23(2):350-8. doi: 10.1038/sj.onc.1207148.
Head and neck squamous cell carcinomas (HNSCC) are characterized by a marked propensity for local invasion and spread to cervical lymph nodes, with distant metastases developing in 30-40% of cases. HPV-16 is an important risk factor for HNSCC. How HPV enhances susceptibility to HNSCC is not fully understood, but seems to involve cofactors. In this study, we examined the effect of the cooperation between HPV-16 and the tyrosine kinase receptor ErbB-2 on E-cadherin/catenin complex patterns and neoplastic transformation of human normal oral epithelial (NOE) cells. We report that overexpression of ErbB-2 or E6/E7 alone does not affect E-cadherin/catenin complex patterns nor does it induce cell transformation of NOE cells. In contrast, coexpression of E6/E7 and ErbB-2 downregulates E-cadherin and catenin expression. This is accompanied by cytoplasmic localization of E-cadherin, as well as nuclear translocation of alpha, beta, and gamma-catenins. Furthermore, we demonstrate that E6/E7 cooperate with overexpressed ErbB-2 to induce tumor formation in nude mice and to upregulate cyclin D1 and c-myc expression. Our data suggest that E6/E7 cooperate with ErbB-2 in head and neck carcinogenesis, at least in part, via the conversion of beta-catenin from a cell adhesion to a nuclear function, that is, to act as a potential transcriptional regulator. This conversion leads to the upregulation of cyclin D1, c-myc and other oncoproteins necessary for alteration of the E-cadherin/catenin complex and cell transformation of NOE cells.
头颈部鳞状细胞癌(HNSCC)的特征是具有明显的局部侵袭倾向,并扩散至颈部淋巴结,30%-40%的病例会发生远处转移。人乳头瘤病毒16型(HPV-16)是HNSCC的一个重要危险因素。HPV如何增加对HNSCC的易感性尚不完全清楚,但似乎涉及辅助因子。在本研究中,我们检测了HPV-16与酪氨酸激酶受体ErbB-2之间的协同作用对人正常口腔上皮(NOE)细胞E-钙黏蛋白/连环蛋白复合体模式及肿瘤转化的影响。我们报告,单独过表达ErbB-2或E6/E7既不影响E-钙黏蛋白/连环蛋白复合体模式,也不诱导NOE细胞的细胞转化。相反,E6/E7与ErbB-2的共表达下调E-钙黏蛋白和连环蛋白的表达。这伴随着E-钙黏蛋白的细胞质定位,以及α、β和γ连环蛋白的核转位。此外,我们证明E6/E7与过表达的ErbB-2协同作用可在裸鼠中诱导肿瘤形成,并上调细胞周期蛋白D1和c-myc的表达。我们的数据表明,E6/E7与ErbB-2在头颈部癌发生过程中至少部分通过将β-连环蛋白从细胞黏附功能转化为核功能来协同作用,即作为一种潜在的转录调节因子发挥作用。这种转化导致细胞周期蛋白D1、c-myc和其他改变E-钙黏蛋白/连环蛋白复合体及NOE细胞转化所需的癌蛋白上调。